Päijänne Tavastia Central Hospital
15
1
2
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 15 trials
100.0%
+13.5% vs industry average
7%
1 trials in Phase 3/4
0%
0 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (15)
PErsonalized TReatment for Endometrial Carcinoma
Role: collaborator
Open and Endoscopic Technique in Female Inguinal Hernia Repair. FemaleHernia
Role: collaborator
Oral Antibiotic Outpatient Therapy vs. Placebo in the Treatment of Uncomplicated Acute Appendicitis
Role: collaborator
Indocyanine Green Fluorescence Imaging in Prevention of Colorectal Anastomotic Leakage
Role: collaborator
Ethyl Glucuronide in Urine Samples of Pregnant Women Within the HUS ja PHHYKY Area
Role: collaborator
Dietary Counseling Coupled With FMT in the Treatment of Obesity and NAFLD - the DIFTOB Study
Role: collaborator
Fecal Microbiota Transplantation and Newly Diagnosed Ulcerative Colitis (UC)
Role: collaborator
Postoperative Pain After Endoscopic TEP vs. Lichtenstein Hernioplasty in Inguinal Hernia Repair
Role: collaborator
Laparoscopic Cholecystectomy or Conservative Treatment in the Acute Cholecystitis of Elderly Patients
Role: collaborator
EVLA and Optimal Timing of Sclerotherapy
Role: collaborator
The Prevalence of Appendiceal Tumours in Periappendicular Abscess
Role: collaborator
Daylight PDT for Actinic Keratoses: a Multicentre Study Comparing Two Photosensitizers (BF-200 ALA Versus MAL)
Role: collaborator
The Recuperation of Patients After Elective Shoulder Surgery Observational Cohort Study
Role: collaborator
Assessment of Molecular Remission by ASO-qPCR After Bortezomib-dexamethasone (Vel/Dex) Followed by ASCT
Role: collaborator
the Use of a IPOM Mesh for Prevention of Parastomal Hernia
Role: collaborator
All 15 trials loaded